Knee-deep in meniscus redesign: the story of Atlanta’s OrthoPreserve
Blog
Confronting the task of delivering scalable amounts of protein to a billion cows
What Pharma really thinks about Startups
Meet the Reluctant Founder who is waging war on Antibiotic Resistant Infections!
How this founder raised $230MM in capital
Targeting the Ribosome: taking on platinum resistance in solid ovarian tumors in a safer way!
Price controls for medicine – a chilling effect for innovators?
How to get funding for your biotech: what investors look for
Finding a cure for the neglected diseases of the world’s poor: an interview with drug discovery superstar Dr. Dennis Liotta
Atlanta life sciences companies in OVERDRIVE: don’t sleep on ‘em!
Making vaccine delivery as simple as the flick of a lighter
Conquering the Disease State with Nolan Townsend
The problem with how people take their medications
Pills are not the only solution to big pain! With Dr. Amy Baxter
Mastering the Single Use Scope: the story of Xenocor
2023 Update: Our past guests - where are they now?
From Jurassic Park to the cutting edge of mRNA innovation: the story of Dr. Pooja Tiwari
Quirky Civil War Medicine Stories to make you chuckle!
Capturing endoscopic surgical procedures on “TV” is now a thing!
Are we on the verge of a biologic breakthrough?
The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative.
Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.